Adrian Rabin
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/33744_arabin_0.jpg?itok=n-MBSsIW)
Filters
Applied Materials $700 million senior notes offering
The investment-grade notes are due 2029
Medtronic €3 billion notes offering
The notes are due 2029, 2036, 2043 and 2053
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
SS&C Technologies $750 million senior notes offering
We advised SS&C Technologies on the high-yield debt offering
Korro Bio $70 million private placement
The PIPE consists of common stock
Intra-Cellular Therapies $500 million stock offering
The shares are listed on the Nasdaq Global Select Market
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Stoke Therapeutics $125 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Select Market
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market